Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis

被引：0
|
作者：
Giuseppe Rosiello
Carlotta Palumbo
Sophie Knipper
Angela Pecoraro
Stefano Luzzago
Pierre-Antoine St-Hilaire
Zhe Tian
Umberto Capitanio
Francesco Montorsi
Shahrokh F. Shariat
Fred Saad
Alberto Briganti
Pierre I. Karakiewicz
机构：
[1] University of Montreal Health Center,Cancer Prognostics and Health Outcomes Unit, Division of Urology
[2] IRCCS San Raffaele Scientific Institute,Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute
[3] University of Brescia,Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health
[4] University Hospital Hamburg-Eppendorf,Martini
[5] University of Turin,Klinik Prostate Cancer Center
[6] European Institute of Oncology,Department of Urology, San Luigi Gonzaga Hospital
[7] Medical University of Vienna,Department of Urology
[8] I.M. Sechenov First Moscow State Medical University,Department of Urology, Comprehensive Cancer Center
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Combination therapy; Cytoreductive nephrectomy; Histology; Kidney cancer; SEER database; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：461 / 472
页数：11
相关论文
共 50 条
  • [31] RETROPERITONEAL LYMPH NODE DISSECTION IS NOT ASSOCIATED WITH SURVIVAL OUTCOMES AMONG PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS
    Gershman, Boris
    Moreira, Daniel
    Thompson, R. Houston
    Boorjian, Stephen
    Lohse, Christine
    Costello, Brian
    Cheville, John
    Leibovich, Bradley
    JOURNAL OF UROLOGY, 2016, 195 (04): : E830 - E830
  • [32] Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?
    Ocak, Birol
    Sahin, Ahmet Bilgehan
    Erturk, Ismail
    Korkmaz, Mustafa
    Erdem, Dilek
    Cakiroglu, Umut
    Karaca, Mustafa
    Dirican, Ahmet
    Olmez, Omer Fatih
    Goktas Aydin, Sabin
    Gokyer, Ali
    Kucukarda, Ahmet
    Gulmez, Ahmet
    Yumuk, Perran Fulden
    Demircan, Nazim Can
    Oyman, Abdilkerim
    Sakalar, Teoman
    Karatas, Fatih
    Demir, Hacer
    Yasin, Ayse Irem
    Deligonul, Adem
    Dakiki, Bahar
    Goktug, Mehmet Refik
    Avci, Okan
    Tacar, Seher Yildiz
    Turhal, Nazim Serdar
    Deniz, Guelhan Ipek
    Kacan, Turgut
    Cubukcu, Erdem
    Evrensel, Tuerkkan
    CURRENT ONCOLOGY, 2024, 31 (09) : 5195 - 5205
  • [33] Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma
    Chang, Y.
    An, H.
    Xu, L.
    Zhu, Y.
    Yang, Y.
    Lin, Z.
    Xu, J.
    BRITISH JOURNAL OF CANCER, 2015, 113 (04) : 626 - 633
  • [34] The prognostic value of TRUB2 in patients with renal clear-cell carcinoma and papillary-cell carcinoma
    Cheng, Xiao-lin
    Xu, Shan-shan
    Wang, Su-ying
    Yu, Qing-xin
    ASIAN JOURNAL OF SURGERY, 2024, 47 (06) : 2775 - 2777
  • [35] Integrated molecular analysis of clear-cell renal cell carcinoma
    Yusuke Sato
    Tetsuichi Yoshizato
    Yuichi Shiraishi
    Shigekatsu Maekawa
    Yusuke Okuno
    Takumi Kamura
    Teppei Shimamura
    Aiko Sato-Otsubo
    Genta Nagae
    Hiromichi Suzuki
    Yasunobu Nagata
    Kenichi Yoshida
    Ayana Kon
    Yutaka Suzuki
    Kenichi Chiba
    Hiroko Tanaka
    Atsushi Niida
    Akihiro Fujimoto
    Tatsuhiko Tsunoda
    Teppei Morikawa
    Daichi Maeda
    Haruki Kume
    Sumio Sugano
    Masashi Fukayama
    Hiroyuki Aburatani
    Masashi Sanada
    Satoru Miyano
    Yukio Homma
    Seishi Ogawa
    Nature Genetics, 2013, 45 : 860 - 867
  • [36] Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
    Munari, Enrico
    Marchionni, Luigi
    Chitre, Apurva
    Hayashi, Masamichi
    Martignoni, Guido
    Brunelli, Matteo
    Gobbo, Stefano
    Argani, Pedram
    Allaf, Mohamad
    Hoque, Mohammad O.
    Netto, George J.
    HUMAN PATHOLOGY, 2014, 45 (06) : 1130 - 1138
  • [37] Evaluation of the efficiency of combination palliative treatment in patients with metastatic clear-cell renal cell carcinoma
    Borisov, P. S.
    Orlova, R. V.
    Shkolnik, M. I.
    Karlov, P. A.
    ONKOUROLOGIYA, 2015, 11 (03): : 55 - 61
  • [38] METASTATIC RENAL TUMOR PRESENTING AS OVARIAN CLEAR-CELL CARCINOMA
    SPENCER, JR
    ERIKSEN, B
    GARNETT, JE
    UROLOGY, 1993, 41 (06) : 582 - 584
  • [39] Integrated molecular analysis of clear-cell renal cell carcinoma
    Sato, Yusuke
    Yoshizato, Tetsuichi
    Shiraishi, Yuichi
    Maekawa, Shigekatsu
    Okuno, Yusuke
    Kamura, Takumi
    Shimamura, Teppei
    Sato-Otsubo, Aiko
    Nagae, Genta
    Suzuki, Hiromichi
    Nagata, Yasunobu
    Yoshida, Kenichi
    Kon, Ayana
    Suzuki, Yutaka
    Chiba, Kenichi
    Tanaka, Hiroko
    Niida, Atsushi
    Fujimoto, Akihiro
    Tsunoda, Tatsuhiko
    Morikawa, Teppei
    Maeda, Daichi
    Kume, Haruki
    Sugano, Sumio
    Fukayama, Masashi
    Aburatani, Hiroyuki
    Sanada, Masashi
    Miyano, Satoru
    Homma, Yukio
    Ogawa, Seishi
    NATURE GENETICS, 2013, 45 (08) : 860 - U191
  • [40] Identifying RHEB as a metastatic driver in clear-cell renal cell carcinoma through bioinformatics analysis
    Lv, Zhiyong
    He, Hao
    Lv, Lindong
    Zhang, Wenbing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07): : 10123 - +
12345